Quick Answer
Intellia Therapeutics, Inc. reported Stockholders Equity of $671.39 million for fiscal year 2025.
Intellia Therapeutics, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $671.39M | -23.0% |
| 2024 | $871.96M | -17.0% |
| 2023 | $1.05B | -15.0% |
| 2022 | $1.24B | +18.8% |
| 2021 | $1.04B | +97.4% |
| 2020 | $527.07M | +95.3% |
| 2019 | $269.88M | -2.9% |
| 2018 | $277.92M | -7.5% |
| 2017 | $300.60M | +43.3% |
| 2016 | $209.84M | +1089.8% |
| 2015 | -$21.20M | -380.2% |
| 2014 | $7.57M | — |
| 2014 | $0.00 | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $748.42M | -22.3% | +4.6% |
| June 30, 2025 | $715.25M | -26.3% | -8.3% |
| March 31, 2025 | $779.92M | -24.7% | -10.6% |
| December 31, 2024 | $871.96M | -17.0% | -9.4% |
| September 30, 2024 | $962.62M | -7.2% | -0.9% |
| June 30, 2024 | $971.06M | -12.1% | -6.3% |
| March 31, 2024 | $1.04B | -13.0% | -1.3% |
| December 31, 2023 | $1.05B | -15.0% | +1.2% |
- Intellia Therapeutics, Inc. showed a decrease of -23.0% in Stockholders Equity compared to the prior fiscal year.
- The most recent figure is from Intellia Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: